Fideliomed Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Early Stage VC
- Investors
-
15
Fideliomed General Information
Description
Developer of an AI-driven diagnostic platform designed for real-time risk prediction. The company offers end-to-end AI-driven diagnostics, real-time point-of-need testing, proactive at-risk patient identification, a unified care pathway platform, seamless specialist access integration, and disease-oriented diagnostic analysis, enabling healthcare providers to deliver efficient disease care.
Contact Information
Website
www.fideliomed.comCorporate Office
- Via Fieno 8
- Milan
- Italy
Corporate Office
- Via Fieno 8
- Milan
- Italy
Fideliomed Timeline
Fideliomed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Early Stage VC | 01-Jan-2025 | Completed | Generating Revenue | |||
| 12. Accelerator/Incubator | 03-Oct-2024 | Completed | Generating Revenue | |||
| 11. Accelerator/Incubator | 30-Jul-2024 | Completed | Generating Revenue | |||
| 10. Angel (individual) | 01-Jan-2024 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 8. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 7. Angel (individual) | Completed | Generating Revenue | ||||
| 6. Grant | 18-Sep-2023 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 08-Sep-2023 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Fideliomed Patents
Fideliomed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4655582-A1 | Method and electroanalytical sensor for detecting and/or quantifying, in a sample of blood or derivate biological liquid, a panel of haematological parameters | Active | 24-Jan-2023 | ||
| US-20260227306-A1 | Method and electroanalytical sensor for detecting and/or quantifying, in a sample of blood or derivate biological liquid, a panel of haematological parameters | Pending | 24-Jan-2023 | ||
| WO-2024157161-A8 | Method and electroanalytical sensor for detecting and/or quantifying, in a sample of blood or derivate biological liquid, a panel of haematological parameters | Inactive | 24-Jan-2023 | ||
| WO-2024157161-A1 | Method and electroanalytical sensor for detecting and/or quantifying, in a sample of blood or derivate biological liquid, a panel of haemotological parameters | Inactive | 24-Jan-2023 | ||
| EP-4655582-B1 | Method for detecting and/or quantifying, in a sample of blood or derivate biological liquid, a panel of haematological parameters | Active | 24-Jan-2023 | G01N15/0656 |
Fideliomed Signals
Fideliomed Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 20 Fund | Venture Capital | Minority | ||
| Fondazione Social Venture | Impact Investing | Minority | ||
| Rigel Ventures | Venture Capital | Minority | ||
| Jumpstart Ventures | Venture Capital | Minority | ||
| Get it! | Accelerator/Incubator |
Fideliomed FAQs
-
When was Fideliomed founded?
Fideliomed was founded in 2022.
-
Where is Fideliomed headquartered?
Fideliomed is headquartered in Milan, Italy.
-
What is the size of Fideliomed?
Fideliomed has 3 total employees.
-
What industry is Fideliomed in?
Fideliomed’s primary industry is Decision/Risk Analysis.
-
Is Fideliomed a private or public company?
Fideliomed is a Private company.
-
What is Fideliomed’s current revenue?
The current revenue for Fideliomed is .
-
Who are Fideliomed’s investors?
20 Fund, Fondazione Social Venture, Rigel Ventures, Jumpstart Ventures, and Get it! are 5 of 15 investors who have invested in Fideliomed.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process